Inventor
HODGSON SIMON TEANBY
GB21 patents
⚠️ This page may combine multiple inventors who share the name “HODGSON SIMON TEANBY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KALVISTA PHARMACEUTICALS LTD
9 patentsUS10611758B2Apr 7, 2020
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD4 citations83
US10364238B2Jul 30, 2019
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD8 citations83
US9533987B2Jan 3, 2017
Heterocyclic derivates
KALVISTA PHARMACEUTICALS LTD19 citations79
US10781181B2Sep 22, 2020
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD6 citations72
US11198691B2Dec 14, 2021
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations61
US11084809B2Aug 10, 2021
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations61
US11001578B2May 11, 2021
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations61
US11180484B2Nov 23, 2021
Pyrazole derivatives as plasma kallikrein inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations56
US11613527B2Mar 28, 2023
Enzyme inhibitors
KALVISTA PHARMACEUTICALS LTD0 citations47
GLAXO GROUP LTD
8 patentsUS7615550B2Nov 10, 2009
Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
GLAXO GROUP LTD17 citations82
US7101882B2Sep 5, 2006
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
GLAXO GROUP LTD8 citations71
US7157457B2Jan 2, 2007
Compounds useful in the treatment of inflammatory diseases
GLAXO GROUP LTD2 citations60
US7560548B2Jul 14, 2009
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
GLAXO GROUP LTD2 citations59
US7622464B2Nov 24, 2009
Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
GLAXO GROUP LTD6 citations57
US7884114B2Feb 8, 2011
Compounds
GLAXO GROUP LTD1 citations50
US8357716B2Jan 22, 2013
Pyrazole derivatives used as CCR4 receptor antagonists
GLAXO GROUP LTD0 citations49
US7989629B2Aug 2, 2011
3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders
GLAXO GROUP LTD1 citations45